Health Information Technology (HIT) and Digital Health are rapidly transforming healthcare systems in the US and around the world. The explosive growth of HIT—spurred by technology innovation, government initiatives, and growing pressure to improve quality, efficiency, and patient experiences—is upending practices, processes, and relationships across the ecosystem and is creating exciting opportunities for companies that understand these trends and have the right strategies in place.
Health Advances leverages its deep understanding of the healthcare system and health technology to help innovators, developers, service providers, and investors navigate and thrive in this evolving ecosystem.
We help clients optimize the value of the solutions they deliver to their customers. To achieve this we facilitate strategy development from answering specific market segment questions to end-to-end business planning.
How We Help Your Business
Valuable perspectives. Actionable results.
Our HIT team has a deep understanding of the healthcare industry, HIT solutions, and technology and market trends. We leverage this expertise to help clients with:
HIT Quality and Analytics: Initiatives that require a deep understanding of data and its potential to answer mission critical questions, quantify clinical or economic value, or derive insights that can improve care or business processes
Digital Health: Solutions that link stakeholders and products together in a more integrated, coordinated, and efficient healthcare system
HIT M&A Strategy and Due Diligence: To enable companies to enhance their product portfolios or capabilities by identifying, screening, and evaluating potentially valuable assets
HIT represents a broad area of industry initiatives and solutions that can significantly improve performance, outcomes and stakeholder satisfaction. Within this landscape Health Advances is specifically focused on helping clients realize their goals for:
This care management approach focuses on the quantifiable impact of the collective interventions for a diagnostic group, procedure, or at-risk population. Health Advances can help clients with the measurement of care impact to support contractual or incentive programs requiring report of outcomes at the point of care or for continuity of care models.
An organized method of caring for groups with common health traits at risk for poor outcomes if not actively managed. Management models focus on risk stratification, identification of best practices for risk groups, and optimizing care coordination over defined time periods. Health Advances works with organizations to design successful programs to meet the needs of these individuals.
All industry stakeholders are looking to mobile health monitoring devices for innovative approaches to managing wellness, medical, or public health programs. Health Advances is helping clients cut through the hype and develop strategies to optimize device use with consideration of the linkages that exist between mobile monitoring, communication, health/wellness content features, EHRs, and support services to round out mHealth offerings.
With the massive investment in the digital capture of health information over the past decade, care management approaches can now leverage health analytics to power decision support and outcomes analysis capabilities to optimize care planning and delivery. The scope of information that can be effectively managed across a network of care bolsters the value of insight that can be derived from Information-Based Health solutions. Health Advances helps clients align information with value drivers to support evidence-based medicine initiatives, leveraging the most appropriate data set available to inform clinical decision making.
The recognition that positive health outcomes are critically dependent on an individuals commitment to their care plan has driven a proactive approach (and systems that support it) to improve care by actively engaging people in their health and healthcare. Health Advances helps organizations design patient engagement solutions focusing on improving patient education, communications with care-givers, and active patient participation in care management decisions.
Healthcare organizations are feeling the increased pressure to demonstrate value for the services they provide or solutions they sell. Health Advances experts help clients analyze care or service line processes and assess their quantitative and/or qualitative impact.
Health Advances Adds BioPharma and Health IT Executives to Senior Leadership Team
Building upon recent additions at the Partner level, Health Advances, LLC has recruited two seasoned healthcare industry leaders, Dean Giovanniello and Greg Chittim, as it continues to broaden and deepen the range of its strategy consulting services. Dean Giovanniello, Vice President, will join the leadership team of Health Advances’ Biopharma practice with a focus on emerging biopharma companies. Greg Chittim, Vice President, will co-lead the Health IT and Digital practice, bringing a mix of technical industry experience in population health analytics and management consulting for biopharma, high tech, and government sectors. These new leaders, along with fifteen colleagues in Health Advances’ senior management, expand and strengthen the leadership team to help continue the firm’s strong record of cross-industry expertise and steady growth as it celebrates its 25th anniversary.
Dean Giovanniello, RPh, joins Health Advances with experience in Commercialization and Launch Excellence in the Emerging Biopharma and Medtech industries. He has expertise in developing go-to-market strategies along with operational plans to support launch decision making across a variety of large and orphan disease segments in the US and EU. Immediately prior to joining Health Advances, Dean was a principal at QuintilesIMS Consulting where he focused on commercialization of assets. He has extensive experience in data sources/analytics, primary and secondary market research to support forecasting as well as commercial strategy informed by P&Ls to drive better decision-making for acquisitions and licensing deals. Prior to this work, Dean was an independent commercial consultant working with start-up companies to optimize their launch planning and execution in a variety of therapeutic areas. He has extensive experience in anti-infectives, CNS, gastroenterology, immunology, metabolic, ophthalmology and oncology. During his twenty-year career on the client side of the business at GlaxoSmithKline and Sepracor/Sunovion, Dean held senior positions in sales and sales management, product management, market research and business development. Over the course of his career, Dean has directed the launch of over 10 NCEs, indications and line extensions in numerous therapeutic areas. His teams were the recipients of multiple CEO awards based on innovative launch programs and sales performance. Dean received a BS in Pharmacy from the Massachusetts College of Pharmacy and Allied Health Sciences and is a Registered Pharmacist in the State of New Jersey. He also received an MBA from Lubin School of Business at Pace University in New York City.
Greg Chittim joins Health Advances with fifteen years of experience in strategy, management consulting, marketing, operations, and technology leadership. A computer engineer and manager by training, Greg’s career has included technical software development and product management; strategic growth consulting to the Fortune 500; product management; B2B marketing and communications; and senior operations leadership. Prior to Health Advances, Greg held multiple senior executive roles at Arcadia Healthcare Solutions, a leader in population health analytics and EHR data integrations serving health systems, accountable care organizations, and health plans nationwide. Greg founded and ran a Strategic Marketing team after an initial round of growth equity and drove company-wide business planning, performance improvement and measurement programs as the Strategic Operations leader. Earlier in his tenure, he was the product director for the core analytics platform and a principal consultant in Arcadia’s legacy consulting business. While at Arcadia, Greg also served as a subject matter expert to the Office of the National Coordinator for HIT on health information exchange (HIE) under the federal HIE, Regional Extension Center, and Beacon Community grant programs. Greg began his career as a case team leader and technical project manager at Monitor Group (now part of Deloitte), serving clients in the biopharma, high tech, and government sectors. Greg holds a Masters of Engineering Management degree from the Thayer School of Engineering at Dartmouth College, a collaborative program with the Tuck School of Business. He holds a BE and BA in Engineering and Computer Science, also from Dartmouth College.
Value-Based Care (VBC) initiatives are capturing a lot of attention, and in some cases capturing scarce IT budget allocations, as health industry stakeholders prepare for what some believe is an inevitable shift in the way care will be financed and delivered. For Health Information Technology (HIT) vendors,
this shift presents a double-edged sword of both new opportunity and risk.
Bruno Nardone, Vice President and Andrew Matzkin, Manager
Selling health IT (HIT) solutions to hospitals and other healthcare providers has never been easy. HIT companies have always faced long, arduous sales cycles and the very real risk that growth will never extend beyond a few early adopters to the broader market.